Shortening blood thinner time with heart artery imaging guidance
Part of Heart & circulation clinical trials.
This trial tests if a shorter course of two blood thinners, guided by an ultrasound inside the arteries, is as safe and effective as the standard longer course in people who have had a stent placed for a heart attack or chest pain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have had a heart procedure to place a stent in a blocked artery, or are about to have one.
- You have had unstable chest pain, a heart attack (with or without ST elevation), or stable chest pain requiring a stent.
- You are willing to take aspirin and a second blood thinner for at least a few months after the procedure.
- You have no history of a stroke or permanent brain injury in the last 3 months.
- You do not have severe kidney disease (on dialysis or eGFR below 20).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a very short course of dual antiplatelet therapy (two blood thinners) after getting a stent is safe and effective for patients aged 65 and older. The goal is to reduce bleeding risks while still preventing heart attacks.
This study tests if doctors can safely use special eye scans (OCT) or angiography to decide when to stop taking two blood thinners (DAPT) after a heart attack and stent placement. It aims to reduce bleeding risks while still protecting your heart.
This trial compares two ways of using anti-platelet (blood-thinner) medicines after a specific kind of heart attack (STEMI) treated with a stent. It aims to see if switching sooner to one medicine (instead of two for longer) works just as well and may reduce risks.
This trial compares 12 months versus 24 months of dual antiplatelet therapy (two blood thinners) after a stent placement in people with high lipoprotein(a) levels. It aims to see if longer treatment reduces heart risks without increasing bleeding.
This study looks at the safest way to handle your blood thinners when you have a colonoscopy. It is for people with stable heart or blood vessel disease who take two blood thinners and need a routine screening or follow-up colonoscopy.
This trial tests switching from a standard blood thinner (clopidogrel) to a lower dose of a stronger one (prasugrel) in people who have had a stent placed and are at high risk for both bleeding and heart problems. The goal is to see if the switch better prevents clots while keeping bleeding risks low.
Hear when a new Coronary Arterial Disease (CAD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.